Market orientation and performance in the biotechnology industry: An exploratory empirical analysis

The purpose ofthis study was to conduct an exploratory investigation into the link between market orientation and business performance in the biotechnology sector. Based on the nature and character of the biotechnology industry, a multi-faceted scale of market orientation was derived from a preuiously tested and refined measure of the construct. Data were generated from 62 biotechnolog firms and a variety of market orientation-performance relationships were investigated, alongside other potential effects on the different dimensions of business performance. The findings indicate that market orientation is positively and signficanttly associated with three of the four performance measures examined. Implications of our findings for biotechnology industry managers are discussed and limitations of the study as well as future research directions are addressed.

[1]  Robert W. Ruekert.  Developing a market orientation: An organizational strategy perspective , 1992 .

[2]  Judy A. Siguaw,et al.  The Influence of the Market Orientation of the Firm on Sales Force Behavior and Attitudes , 1994 .

[3]  J. J. Cronin,et al.  An Examination of the Relative Impact of Growth Strategies on Profit Performance , 1988 .

[4]  Mark D. Dibner,et al.  Patterns of Strategic Choice in Emerging Firms: Positioning for Innovation in Biotechnology , 1990 .

[5]  B. Golden,et al.  SBU strategy and performance: The moderating effects of the corporate‐SBU relationship , 1992 .

[6]  Leyland Pitt,et al.  Market orientation and business performance: some European evidence , 1996 .

[7]  John C. Narver,et al.  The Effect of a Market Orientation on Business Profitability , 1990 .

[8]  J. Pearce,et al.  Planned patterns of strategic behavior and their relationship to business-unit performance† , 1988 .

[9]  C. Fornell,et al.  Customer Satisfaction, Market Share, and Profitability: Findings from Sweden , 1994 .

[10]  G. Davies,et al.  Market orientation in UK multiple retail companies: Nature and pattern , 1997 .

[11]  Les Levidow,et al.  Biotechnology regulation as symbolic normalization , 1994 .

[12]  Ray Loveridge,et al.  The strategic management of technological innovation , 1993 .

[13]  Joyce Tait,et al.  Management of agriculture-related biotechnology constraints on innovation , 1993 .

[14]  Gregory G. Dess,et al.  Measuring organizational performance in the absence of objective measures: The case of the privately-held firm and conglomerate business unit , 1984 .

[15]  Gilbert A. Churchill.  A Paradigm for Developing Better Measures of Marketing Constructs , 1979 .

[16]  Gordon E. Greenley.  Market Orientation and Company Performance: Empirical Evidence From UK Companies , 1995 .

[17]  Bernard J. Jaworski,et al.  Market orientation: Antecedents and consequences , 1993 .

[18]  A. Parasuraman,et al.  SERVQUAL: A multiple-item scale for measuring consumer perceptions of service quality. , 1988 .

[19]  K. Atuahene–Gima,et al.  Market Orientation and Innovation , 1996 .

[20]  Gilbert A. Churchill,et al.  Research Design Effects on the Reliability of Rating Scales: A Meta-Analysis: , 1984 .

[21]  Jacqueline Senker,et al.  Organizational Learning in Cooperative Alliances: Some Case Studies in Biotechnology , 1997 .

[22]  R. Cooper.  New Product Strategies: What Distinguishes the Top Performers? , 1984 .

[23]  Patterns of Marketing Activity Among Architectural Design Firms , 1994 .

[24]  Bernard J. Jaworski,et al.  Market orientation: The construct, research propositions, and managerial implications. , 1990 .

[25]  D. Aaker.  Managing Assets and Skills: The Key to a Sustainable Competitive Advantage , 1989 .

[26]  Ursula Weisenfeld-Schenk,et al.  Technology strategies and the Miles & Snow typology: a study of the biotechnology industries , 1994 .